| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 63,640,000 | | Cost of Revenue | 47,263,000 | | | Gross Profit | 16,377,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 6,001,000 | | Non Recurring | 84,000 | | Others | 44,000 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 10,248,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 217,000 | | Earnings Before Interest And Taxes | 10,465,000 | | Interest Expense | 528,000 | | Income Before Tax | 9,937,000 | | Income Tax Expense | 2,787,000 | | Minority Interest | (260,000) | | | | Net Income From Continuing Ops | 6,890,000 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 6,890,000 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $6,890,000 |
|
0.22% Nasdaq 
Income Statement
